These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 30482913)
1. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis. Gilbert DC; Wakeham K; Langley RE; Vale CL Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913 [TBL] [Abstract][Full Text] [Related]
2. Risk of human papillomavirus-associated cancers among persons with AIDS. Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510 [TBL] [Abstract][Full Text] [Related]
3. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review. Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951 [TBL] [Abstract][Full Text] [Related]
4. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275 [TBL] [Abstract][Full Text] [Related]
5. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Nelson RA; Lai LL Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917 [TBL] [Abstract][Full Text] [Related]
6. Cancer incidence in Germany attributable to human papillomavirus in 2013. Buttmann-Schweiger N; Deleré Y; Klug SJ; Kraywinkel K BMC Cancer; 2017 Oct; 17(1):682. PubMed ID: 29037233 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status. Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641 [TBL] [Abstract][Full Text] [Related]
8. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145 [TBL] [Abstract][Full Text] [Related]
9. StatBite: Proportion of specific cancers caused by HPV. J Natl Cancer Inst; 2010 Jun; 102(12):839. PubMed ID: 20530763 [No Abstract] [Full Text] [Related]
10. Five-year relative survival for human papillomavirus-associated cancer sites. Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738 [TBL] [Abstract][Full Text] [Related]
11. HPV-related cancers after solid organ transplantation in the United States. Madeleine MM; Finch JL; Lynch CF; Goodman MT; Engels EA Am J Transplant; 2013 Dec; 13(12):3202-9. PubMed ID: 24119294 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820 [TBL] [Abstract][Full Text] [Related]
13. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea. Choi I; Lee D; Son KB; Bae S BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infection by anatomical site among Greek men and women: a systematic review. Tsikis S; Hoefer L; Charnot-Katsikas A; Schneider JA Eur J Cancer Prev; 2016 Nov; 25(6):558-71. PubMed ID: 26628088 [TBL] [Abstract][Full Text] [Related]
15. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039 [TBL] [Abstract][Full Text] [Related]
16. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review. Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098 [TBL] [Abstract][Full Text] [Related]
17. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples. Lindquist S; Frederiksen K; Petersen LK; Kjær SK Int J Cancer; 2024 Jul; 155(1):61-70. PubMed ID: 38418719 [TBL] [Abstract][Full Text] [Related]
18. Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007. Kurdgelashvili G; Dores GM; Srour SA; Chaturvedi AK; Huycke MM; Devesa SS Cancer; 2013 Jun; 119(12):2291-9. PubMed ID: 23580435 [TBL] [Abstract][Full Text] [Related]
19. Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study. Bertoli HK; Thomsen LT; Iftner T; Dehlendorff C; Kjær SK Gynecol Oncol; 2020 May; 157(2):456-462. PubMed ID: 32008794 [TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus-Attributable Cancers - United States, 2012-2016. Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]